Therapy Improves Stem Cell Engraftmentin Umbilical Cord Blood Transplant Recipients
Monday, December 12, 2011 - 18:30
in Health & Medicine
A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases, a phase I clinical trial led by Dana-Farber Cancer Institute scientists indicates.